There is a growing recognition around the world that the prohibition of drugs is a counterproductive failure. However, a major barrier to drug law reform has been a widespread fear of the unknown – just what could a post-prohibition regime look like?
For the first time, 'After the War on Drugs: Blueprint for Regulation' answers that question by proposing specific models of regulation for each main type and preparation of prohibited drug, coupled with the principles and rationale for doing so.
We demonstrate that moving to the legal regulation of drugs is not an unthinkable, politically impossible step in the dark, but a sensible, pragmatic approach to control drug production, supply and use.
Watch Steve Rolles, Blueprint's author, discussing the book on CNN
Praise for After the War on Drugs:
Blueprint for Regulation
"In a beautifully argued essay [in the BMJ, summarising Blueprint] Stephen Rolles calls on us to envisage an alternative to the hopelessly failed war on drugs. He says, and I agree, that we must regulate drug use, not criminalise it."
Editor of the British Medical Journal
"Drugs should still be regulated, and the argument for decriminalising them is clearly made byStephen Rolles in the latest edition of the BMJ [the BMJ article summarises Blueprint]."
Professor Sir Ian Gilmore
President of the Royal College of Physicians
"This is the most thorough, evidence-based, balanced discussion of how we might move towards a more rational drugs control policy that I have seen. It should be compulsory reading for all our policy makers."
Professor Emeritus of Criminal Justice, former HM Chief Inspector of Probation and Chairman of the Youth Justice Board for England and Wales
"This book presents a starting point for critical healthy debate and discussion about how the global community can learn from the failures of current drug policy and build the next generation of constructive and pragmatic reforms."
Executive Director, International AIDS Society
"The book's arguments and proposals should provide food for thought for any enlightened healthcare professional." - Andrew Haynes
The Pharmaceutical Journal